A Clinical Trial to Evaluate the Efficacy and Safety of HL-1186 Tablet in the Treatment of Postherpetic Neuralgia

Clinical trial NCT07758920 · RECRUITING

Trial details

NCT number: NCT07758920
Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Postherpetic Neuralgia ( PHN )

Start date: 2026-08-01
Primary completion: 2027-06-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.